Sun Pharma drops over 5 percent; shares hit 52-week low
New Delhi: Shares of Sun Pharmaceutical Industries fell by over 5 per cent amid reports that its subsidiary Taro Pharmaceutical Industries reported weak quarterly numbers.
The stock plunged 5.13 per cent to settle at Rs 474.75 on BSE. During the day, it slumped 5.63 per cent to Rs 472.20 -- its 52-week low.
The scrip was the worst hit among the BSEs 30-share index pack.
On NSE, it dipped 5.19 per cent to close at Rs 474.35.
In terms of equity volume, 11.50 lakh shares of the company were traded on BSE and over one crore shares changed hands at NSE during the day.
The stock has slipped for the 6th straight trading session, down over 11 per cent wiping out Rs 14,373.78 crore from its market valuation.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd